Literature DB >> 12091433

P2 purinergic receptor-coupled signaling in the rabbit ciliary body epithelium.

Nasser A Farahbakhsh1, Marianne C Cilluffo.   

Abstract

PURPOSE: To identify and characterize P2 purinergic receptors and their signaling pathways in the epithelial cells of the rabbit ciliary body.
METHODS: Real-time fluorescence ratio imaging of the intact fura-2-loaded nonpigmented ciliary body epithelial (NPE) cells of rabbit were used to record changes in the intracellular free calcium concentration ([Ca(2+)](i)), in response to a number of purinergic agonists and antagonists. The effects of some of these drugs on the inositol phosphate (IP) levels in ciliary processes were also examined.
RESULTS: Adenosine diphosphate (ADP), adenosine triphosphate (ATP), and uridine triphosphate (UTP) dose dependently increased the [Ca(2+)](i) and IP levels. The [Ca(2+)](i) increases induced by ADP and UTP were distinguishable, both kinetically and pharmacologically. The effect of ADP on [Ca(2+)](i) was mimicked by a number of P2Y(1)-selective agonists, and was blocked by three P2Y(1)-receptor-specific antagonists. The [Ca(2+)](i) increases elicited by ADP (or its analogs) and UTP were additive.
CONCLUSIONS: Rabbit ciliary body epithelium possesses both P2Y(1) and P2Y(2) metabotropic purinergic receptor subtypes, which differentially use the IP(3)/Ca(2+) second-messenger pathway.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12091433

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  6 in total

1.  Silencing of P2Y(2) receptors reduces intraocular pressure in New Zealand rabbits.

Authors:  Alba Martin-Gil; María Jesús Perez de Lara; Almudena Crooke; Concepción Santano; Assumpta Peral; Jesus Pintor
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 2.  The developmental journey of therapies targeting purine receptors: from basic science to clinical trials.

Authors:  Seunga Han; Haruna Suzuki-Kerr; Srdjan M Vlajkovic; Peter R Thorne
Journal:  Purinergic Signal       Date:  2022-09-29       Impact factor: 3.950

Review 3.  P2Y2 receptor agonists for the treatment of dry eye disease: a review.

Authors:  Oliver C F Lau; Chameen Samarawickrama; Simon E Skalicky
Journal:  Clin Ophthalmol       Date:  2014-01-30

Review 4.  Purinergic receptors in ocular inflammation.

Authors:  Ana Guzman-Aranguez; Xavier Gasull; Yolanda Diebold; Jesús Pintor
Journal:  Mediators Inflamm       Date:  2014-07-14       Impact factor: 4.711

5.  Changes in P2Y Purinergic Receptor Expression in the Ciliary Body in a Murine Model of Glaucoma.

Authors:  Begoña Fonseca; Alejandro Martínez-Águila; María J Pérez de Lara; Maria Teresa Miras-Portugal; Rosa Gómez-Villafuertes; Jesús Pintor
Journal:  Front Pharmacol       Date:  2017-10-10       Impact factor: 5.810

6.  Immunolocalisation of P2Y receptors in the rat eye.

Authors:  Jesús Pintor; Jesús Sánchez-Nogueiro; Marta Irazu; Aranzazu Mediero; Teresa Peláez; Assumpta Peral
Journal:  Purinergic Signal       Date:  2004-12       Impact factor: 3.765

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.